6Cox JD,Stetz J,Pajak TF.Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC)[J].Int J Radiat Oncol Biol Phys,1995,31(5):1341-1346.
7Choy H,Vokes E.Improving outcomes in the treatment of locally advanced NSCLC with gemcitabine[J].Lung Cancer,2005,50(1):10-12.
8Werner-Wasik M,Pequignot E,Hauck W.A multivariate analysis of esophagitis grade and esophagitis index in patients with lung cancer[J].Int J Radiat Oncol,1999,45(3):154-155.
9Langer C,Hudes R,Movsas B,et al.,Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in unresectable,locally advanced non-small cell lung carcinoma[J].Lung Cancer,1997,18(1):74-79.
10Maguire J,Kelly V,Page R,et al.Accelerated hypofractionated radical radiotherapy concurrent with cisplatinum and vinorelbine for inoperable NSCLC[J].Lung Cancer,2005,49(2):171-175.
